Cyclin D-dependent kinases phosphorylate the retinoblastoma (Rb) protein and play a critical role in neuronal cell cycle control and apoptosis. Here we show that cyclin D1 became predominantly cytoplasmic as primary cortical progenitor cells underwent cell cycle withdrawal and terminal differentiation. Furthermore, ectopically expressed cyclin D1 sequestered in the cytoplasm of postmitotic neurons, whereas it efficiently entered the nucleus of proliferating progenitor cells. Cytoplasmic cyclin D1 were complexed with cyclin-dependent kinase 4 (CDK4), and also with CDK inhibitors, p27
Introduction
Proliferating neural progenitor cells undergo final cell division leading to terminal differentiation through continuous processes involving cell division, migration, and maturation during embryogenesis. A distinctive property of terminally differentiated neurons is irreversible withdrawal from the cell cycle, in contrast to reversible quiescent cells, such as serum-starved fibroblasts, which retain the capacity to re-enter the cell cycle in response to growth factors. The retinoblastoma (Rb) tumor suppressor protein, a key regulator of the mammalian cell cycle, is critical for the cell cycle withdrawal, differentiation and survival of neurons (reviewed by Ferguson and Slack, 2001) .
Cyclin D1 and its catalytic enzymes, cyclin-dependent kinase 4 (CDK4) and CDK6, promote G1-to-S phase progression by Rb phosphorylation, a process that inactivates the ability of Rb to suppress the transcription factor E2F that regulates genes required for cell cycle progression and DNA replication (reviewed by Weinberg, 1995; Sherr and Roberts, 1999) . Furthermore, cyclin D-CDK complexes sequester the Cip/Kip family of CDK inhibitors (CKIs), including p21 CIP1 and p27 KIP1 , and thereby lead to activation of the cyclin E-CDK2 and cyclin A-CDK2 complexes. These CKIs inhibit the activity of both cyclin D-CDK4/CDK6 and cyclin A/cyclin E-CDK2 complexes, and the levels of p21 and p27 are regulated during the cell cycle. Generally, p27 levels are high in quiescent cells and low in proliferating cells, whereas p21 levels are elevated upon mitogenic stimulation. Conversely, p21 and p27 also positively regulate the activity of cyclin D-CDK4/ CDK6. These inhibitors possess a cluster of nuclear localization signals (NLSs) and are essential for the assembly and efficient nuclear accumulation of the cyclin D-CDK complex (LaBaer et al., 1997; Cheng et al., 1999) . In addition, the activity of the cyclin D-CDK complex is regulated by its subcellular localization during the cell cycle. Cyclin D1 accumulates in the nucleus during the G1 phase and is exported to the cytoplasm when cells enter the S phase. Cyclin D1 nuclear export is regulated by the phosphorylation of cyclin D1 at threonine 286 via glycogen synthase kinase 3b (GSK-3b), which facilitates the binding of cyclin D1 with the nuclear exportin CRM1, thereby targeting cyclin D1 for cytoplasmic proteolysis (Diehl et al., 1998; Alt et al., 2000) .
Cyclin D-dependent kinase activity is downregulated during differentiation (Kranenburg et al., 1995; Gill et al., 1998) . Nevertheless, significant levels of cyclin D1 are still detected in postmitotic neurons (Tamaru et al., 1994; Ferguson et al., 2000) . Furthermore, growing evidence suggests that cyclin D1 activity appears to play a role in the death of postmitotic neurons under certain cases of apoptotic conditions (reviewed by Liu and Greene, 2001 ). For instance, cyclin D1 is induced in dying neurons, and cyclin D1-dependent kinase activity is elevated in primary cortical and sympathetic neurons following DNA damage or KCl withdrawal (Freeman et al., 1994; Park et al., 1997b Park et al., , 1998 Padmanabhan et al., 1999) . Furthermore, the inhibition of cyclin D-dependent kinase promotes the survival of primary sympathetic and cortical neurons under a variety of apoptotic conditions (Park et al., 1997a (Park et al., , b, 1998 Giovanni et al., 1999; Osuga et al., 2000; Copani et al., 2001; Ino and Chiba, 2001) .
Recently, we demonstrated that cyclin D1 nuclear import is inhibited in postmitotic primary cardiomyocytes, another example of terminally differentiated cells, and that nuclear import of cyclin D1-CDK4 induces cell cycle progression leading to cell division (TamamoriAdachi et al., 2003) . These observatios prompted us to examine the posibility that subcellular localization of cyclin D1 might contribute to the suvival and/or cell cycle exit of postmitotic neurons. The results suggest a role of the cytoplasmic sequestration of cyclin D1 in the survival of postmitotic neurons.
Results

Cytoplasmic localization of D-type cyclins in differentiated cortical neurons
Cortical progenitor cells isolated from 15.5-day embryos (E15.5), containing a cell population of proliferating progenitor cells, were cultured to allow differentiation in vitro. Laser scanning cytometry (LSC) analysis shows that typically 80-90% of cells were arrested in a G0/G1 cell population, 4 days after culture (Figure 1a) . To examine the subcellular localization of D-type cyclins during neuronal differentiation, cortical progenitor cells were double-stained with anticyclin D, which recognizes all three D-type cyclins, together with antinestin and MAP2 antibodies, which detect a major marker specific for neuronal progenitor cells and differentiated neurons, respectively. We routinely obtained cultures that contained over 90% of MAP2-positive neurons after 4 days. Figure 1b shows that D-type cyclins were localized in both the nucleus and cytoplasm in nestin-positive cells cultured for 1 day (day 1), but became exclusively cytoplasmic in the MAP2-positive cells (day 4). Similar results were obtained by using antibodies against cyclin D1 and neuron-specific type III b-tubulin (Figure 1c) . Again, cyclin D1 was localized in both the nucleus and cytoplasm of freshly isolated progenitor cells (day 0), but predominantly in the cytoplasm of differentiated neurons (day 4).
Consistent with these results, Western blotting analysis of nuclear and cytoplasmic extracts revealed that cyclin D1 localized in both the nucleus and cytoplasm of proliferating progenitor cells (day 0), and became predominantly cytoplasmic with reduced but considerable levels in differentiated neurons (Figure 2a) . Furthermore, CDK4 and p27, which were detected in both the nucleus and cytoplasm of proliferating progenitor cells, were also downregulated and predominantly localized in the cytoplasm after differentiation, whereas CDK6 and p21, as well as other D-type cyclins (D2 and D3), were hardly detected in the nucleus of proliferating progenitor cells. Quantitation of the nuclear-to-cytoplasmic (N/C) ratios of cyclin D1 by using two cyclin D1 antibodies (Ab-3 and 72-13G) confirmed that nuclear cyclin D1 ratios were dramatically reduced in differentiated neurons, regardless of the antibodies used (Figure 2b ). Similar results were obtained with CDK4 (data not shown). In concert with the cytoplasmic localization of cyclin D1 and CDK4, Rb, which was predominantly nuclear, became underphosphorylated and decreased during differentiation. Along with this, E2F1, a downstream target of Rb, decreased to undetectable levels in differentiated progenitor cells (day 10).
Cytoplasmic localization of exogenous cyclin D1 in differentiated neurons
We next asked whether nuclear localization of cyclin D1 is inhibited in differentiated neurons or whether its cytoplasmic localization merely reflects the overall reduction of cyclin D1 levels after differentiation. To this end, we overexpressed cyclin D1 and CDK4 using recombinant adenoviruses encoding cyclin D1 and CDK4 (Ad-cyclin D1 and Ad-CDK4, respectively), either at the day of plating (day 0) or after 2 days in culture (day 2), and assessed their expression and subcellular localization by Western blotting, 48 h following infection. Figure 3a shows that ectopic cyclin D1 efficiently entered the nucleus of proliferating neurons (day 0) but hardly accumulated in the nuclear fraction of differentiated neurons (day 2), even though both stages of cells expressed comparable levels of exogenous cyclin D1 (Figure 3a , lane 4 vs lane 10).
Furthermore, immunofluorescent staining confirmed that ectopic cyclin D1 was predominantly cytoplasmic in differentiated neurons (b-tubulin-positive), whereas a variant of cyclin D1 that was fused to triplicated NLSs Cytoplasmic sequestration of cyclin D1 in neurons P Sumrejkanchanakij et al at the C-terminal end of this protein (D1NLS) (Tamamori-Adachi et al., 2003) entered the nucleus of neurons (Figure 3a-c) . However, cyclin D1 overexpression caused its nuclear localization in a small population of the b-tubulin-negative cells, which are likely to be non-neuronal cells or undifferentiated progenitor cells occurring in our neuronal cultures, suggesting that these cells may account for a slight increase of cyclin D1 in the nuclear fraction detected by Western blotting (Figure 3a , lane 9). Collectively, these results indicate that the nuclear localization of cyclin D1 is inhibited in differentiated neurons, and that proliferating cortical progenitor cells lose the ability to import cyclin D1 in the nucleus during differentiation.
Inhibition of cyclin D1 nuclear import contributes to its cytoplasmic sequestration
We next examined whether cytoplasmic cyclin D1 assembles with CDK4 in differentiated neurons. Nuclear and cytoplasmic extracts of differentiated neurons infected with Ad-cyclin D1 and Ad-CDK4 were first immunoprecipitated with anti-CDK4 antibody, followed by Western blotting of cyclin D1. As shown in Figure 4a , left panel, cyclin D1 was coimmunoprecipitated with CDK4 from cytoplasmic extracts. Furthermore, p21 and p27 were also coimmunoprecipitated with CDK4, and the interaction of p21 with cyclin D1 was confirmed by the presence of cyclin D1 in p21 immunoprecipitates (Figure 4a , right panel). Although exogenous CDK4 was detected in the nucleus, cyclin D1 and these CKIs were not coimmunoprecipitated with the nuclear CDK4 (Figure 4a , left panel, lanes 3 and 5). These results indicate that cyclin D1-CDK4 formed ternary complexes with p27 and to a lesser extent p21 in the cytoplasm of postmitotic neurons.
Given that p21 promotes the nuclear accumulation of cyclin D1 (LaBaer et al., 1997; Cheng et al., 1999) , we next examined whether overexpression of p21 causes cyclin D1 nuclear import in postmitotic neurons. Coexpression of p21 with cyclin D1 and CDK4 promoted cyclin D1 nuclear accumulation in differentiated neurons (Figure 4b , left panel, lane 3). Furthermore, the presence of cyclin D1 in p21 immunoprecipitates indicated that the ternary cyclin D1-CDK4 complex containing p21 was formed in the nucleus (Figure 4b , right panel).
Cyclin D1 nuclear export is mediated by GSK-3b activity (Diehl et al., 1998; Alt et al., 2000) and p21 inhibits CRM1-dependent nuclear export of cyclin D1 (Alt et al., 2002) . We thus investigated whether the cytoplasmic localization of cyclin D1 results from an increase in its rate of nuclear export in differentiated progenitor cells. Western blotting analysis detected an increase of nuclear GSK-3b levels as the cells underwent differentiation (Figure 2a , days 4 and 10). To determine Figure 4 Cyclin D1 assembles with CDK4, and p21 or p27 in the cytoplasm of differentiated cortical progenitor cells. (a) Left panel: Cell extracts infected with Ad-cyclin D1 (D1) and Ad-CDK4 (K4) at 2 days in culture were immunoprecipitated (IP) with anti-CDK4 antibody followed by Western blotting using anticyclin D1, p21, p27 and CDK4 antibodies. Right panel: The extracts were immunoprecipitated with anti-p21 antibody followed by Western blotting using anticyclin D1 and p21 antibodies. (b) Left panel: Cortical progenitor cells at 2 days in culture were coinfected with adenovirus expressing p21 (at 150 MOI) and/or GSK-3bdn (at 150 MOI), together with Ad-cyclin D1 and Ad-CDK4 as described above. Nuclear and cytoplasmic extracts were prepared 48 h postinfection and assessed for Western blotting using the indicated antibodies. Right panel: The extracts were immunoprecipitated with anti-p21 antibody followed by Western blotting using anticyclin D1 and p21 antibodies. (c) Cortical progenitor cells were infected with Ad-cyclin D1 and Ad-CDK4. Nuclear and cytoplasmic extracts were prepared 48 h postinfection and assessed by Western blotting using anticyclin D1 antibody. Where indicated, cells were treated with LMB (10 ng/ml) for 2 h prior to harvest or with increasing concentrations of LiCl (3 and 30 mm)
Cytoplasmic sequestration of cyclin D1 in neurons P Sumrejkanchanakij et al if inhibition of cyclin D1 nuclear export could cause its nuclear localization, we inhibited GSK-3b activity by using an adenovirus expressing a dominant-negative mutant of GSK-3b (GSKdn). GSKdn expression significantly inhibited the phosphorylation of endogenous tau protein, another GSK-3b substrate, as determined by using a phospho-specific tau antibody (Thr181) (Xie et al., 1998) (Figure 4b, left panel) . Expression of this mutant, however, did not promote nuclear accumulation of exogenous cyclin D1 nor facilitate its nuclear import caused by p21 overexpression (Figure 4b, lanes 5 and 7) . Similar results were obtained with lithium chloride (LiCl) treatment (Figure 4c ). Furthermore, treatment of leptomycin B (LMB), which has been shown to inhibit cyclin D1 nuclear export via inhibition of CRM1 (Alt et al., 2000) , had no effect on cyclin D1 nuclear localization ( Figure 4c ). Thus, inhibition of nuclear import, rather than acceleration of its nuclear export, is likely to contribute to cytoplasmic sequestration of cyclin D1 in postmitotic neurons.
Apoptotic induction by cyclin D1 nuclear import in differentiated neurons
It has been shown that transfection of cyclin D1 into growing neuroblastoma cells induces apoptosis (Kranenburg et al., 1996) . We therefore examined the effect of nuclear localization of cyclin D1 on differentiated progenitor cells. To promote cyclin D1 nuclear import, cortical progenitor cells were infected with Ad-D1NLS either alone or coinfected with Ad-CDK4. Since infection efficiencies dramatically reduced after 4 days in culture, we infected the cells after 2 days in cultures and harvested 2 days postinfection. Cell cycle analysis using LSC revealed that the nuclear-tagged cyclin D1 (D1NLS) alone induced apoptosis in a dose-dependent manner as indicated by an increase of cells with sub-G1 DNA content (sub-G1 ¼ 46% at 200 multiplicity of infection (MOI)) compared to the control virus (sub-G1 ¼ 7% at the same MOI), and that coexpression of CDK4 facilitated apoptotic induction without a significant increase of S and G2/M fractions (Figure 5a ). To confirm that cyclin D1 nuclear localization is correlated with neuronal cell death induced by the infection of the D1NLS and CDK4 viruses, we performed in situ terminal transferase-mediated dUTP nick end labeling (TUNEL) assay (red) and then examined the subcellular localization of D1NLS protein in the infected cells by immunofluorescent staining using anticyclin D1 antibody (green). Representative immunofluorescence results are shown in Figure 5b . The number of TUNEL-positive cells in the infected cells (D1NLS-positive) were then determined. Figure 5c shows that approximately 90% TUNEL-positive nuclei were detected in the cells expressing nuclear-localized cyclin D1 (N and N þ C), whereas only 1978% cells were TUNEL-positive in the cells expressing this protein predominantly in the cytoplasm (C). In contrast to D1NLS, which consistently induced apoptosis, wild-type expression caused an increase of apoptotic cells to a lesser extent, the degree of which varied among experiments (sub-G1 ¼ 10-20%) (data not shown and see below). p21 promotes the nuclear accumulation of cyclin D1 in differentiated cortical progenitor cells (Figure 4b ) and is contained in the active cyclin D1 complex (LaBaer et al., 1997; Cheng et al., 1999) . To examine whether nuclear translocation of wild-type cyclin D1 can induce apoptotic cell death, we asked if coexpression of p21 with wild-type cyclin D1 might promote apoptosis in differentiated cortical progenitor cells. Cells after 2 days in cultures were infected with Ad-cyclin D1 and CDK4 (each at 50 Figure 5 Ectopic expression of cyclin D1 in the nucleus induces cell death in differentiated cortical progenitor cells. Cortical progenitor cells after 2 days in culture were infected with the indicated viruses as in Figure 4a , and then fixed at 48 h following infection. (a) Apoptotic induction by nuclear-tagged cyclin D1. Cells were infected with either control Adx1w1 virus with an empty expression cassette (con), or combinations of Ad-D1NLS (D1NLS) and Ad-CDK4 (K4) at the indicated MOIs, and then subjected to LSC analysis as in Figure 1a . The population of apoptotic cells (sub-G1) was determined according to DNA content (PI fluorescence value). (b and c) Cyclin D1 nuclear localization correlates with apoptotic induction. Cells were infected with Ad-D1NLS and Ad-CDK4 at 50 MOI, and then subjected to TUNEL assay (red) followed by cyclin D1 staining (green) Cytoplasmic sequestration of cyclin D1 in neurons P Sumrejkanchanakij et al MOI), together with increasing amounts of Ad-p21. LSC analysis revealed that, although D1NLS/CDK4 significantly induced apoptosis (33%), wild-type cyclin D1/CDK4 increased slightly sub-G1 population compared to the control virus in this setting (16 vs 9%) (Figure 5d) . Coinfection of the p21 virus at a lower MOI (50) promoted apoptotic induction (35%), whereas a subtle increase (18%) was observed at a higher MOI (100), which is consistent with the fact that the excess of this CDK inhibitor suppresses cyclin D1-dependent kinase activity. Collectively, these results indicate that cyclin D1 nuclear import can induce apoptosis in differentiated neuronal progenitor cells.
The DNA topoisomerase-I inhibitor camptothecin has been shown to induce reactivation of cyclin D1-dependent kinase activity, leading to neuronal cell death in cortical neurons (Park et al., 1997b (Park et al., , 1998 . To examine physiological relevance of cyclin D1 nuclear import in neuronal cell death, cortical progenitor cells differentiated for 4 days were incubated with camptothecin, and then examined for the subcellular localization of cyclin D1 by immunofluorescence staining and Western blotting. LSC analysis revealed that the majority (81%) of neurons underwent apoptosis within 24 h after the treatment (Figure 6a) . Consistent with previous studies (Padmanabhan et al., 1999; Timsit et al., 1999; Ino and Chiba 2001) , cyclin D1 was localized in the nuclei of apoptotic neurons (24 h) with aberrant patterns of neuron-specific b-tubulin distribution (Figure 6b ). Furthermore, its nuclear staining was also detected in a number of preapoptotic neurons (sub-G1 ¼ 9%) 8 h after camptothecin treatment (Figure 6b) . Western blotting analysis revealed that camptothecin treatment caused a significant increase of nuclear cyclin D1 levels within 2 h, without the induction of cyclin D1 protein levels (Figure 6c) . Coinciding with this, hyperphosphorylated Rb was detected by an antibody specific to phosphorylated Rb on Ser780, a site that is specifically phosphorylated by cyclin D-dependent kinase (Kitagawa et al., 1996) . Finally, p27 entered the nucleus as nuclear cyclin D1 accumulated, whereas p21 did not, supporting the notion that endogenous p27 protein primarily formed a ternary complex with cyclin D1-CDK4 in differentiated cortical neurons (Figure 4a ). Taken together, these results indicate that cyclin D1 cytoplasmic sequestration is abrogated under apoptotic conditions and suggest that the regulation of its subcellular localization may play a critical role in the survival of postmitotic neurons.
Discussion
Here we show that proliferating progenitor cells lose the ability to import cyclin D1 during differentiation, and that the nuclear accumulation of the cyclin D1-CDK4 complex is inhibited in postmitotic neurons. A recent study has reported that overexpression of cyclin D1 can induce re-entry into the cell cycle from the terminally differentiated state in various types of established cells, including neurons derived from P19 embryonal carcinoma cells (Latella et al., 2001) . Results presented here, however, indicate that inhibition of cyclin D1 nuclear localization appears to be a feature of terminally differentiated neurons derived from normal tissues, which is supported by our recent findings that cyclin D1 nuclear localization was inhibited in primary neonatal cardiomyocytes (Tamamori-Adachi et al., 2003) .
Previous studies have demonstrated that inhibition of CRM1-dependent nuclear export by LMB promotes efficient nuclear localization of cyclin D1 in primary mouse embryonic fibroblasts (MEFs) lacking both p21 and p27 (Cheng et al., 1999; Alt et al., 2000) , and that p21 promotes cyclin D1 nuclear accumulation through inhibition of CRM1-dependent nuclear export (Alt et al., 2002) . However, our results indicate that, although overexpression of p21 promoted nuclear accumulation of cyclin D1, inhibition of either GSK-3b or CRM1 activity did not in postmitotic neurons, suggesting that the blockade of cyclin D1 nuclear import accounts for the cytoplasmic sequestration of the cyclin D1-CDK4 complex in postmitotic neurons. Recent studies have shown that phosphorylation of p21 and p27 inhibits their nuclear localization (Rodier et al., 2001; Zhou et al., 2001) . For instance, the Akt kinase activity promotes the cytoplasmic sequestration of p21 (Zhou et al., 2001) . The association of p21 and p27 with the cyclin D1-CDK4 complex in postmitotic neurons suggests the possibility that phosphorylation of these CDK inhibitors might contribute to cytoplasmic sequestration of the cyclin D1-CDK4 complex. Nevertheless, inhibition of Akt kinase activity did not cause any detectable nuclear import of cyclin D1 in differentiated neurons (data not shown). Given that p27 appears to be a major assembly factor of the cyclin D1-CDK4 complex in postmitotic neurons (Figure 4a) , phosphorylation of p27 might contribute to cytoplasmic sequestration of the cyclin D1-CDK4 complex. Further studies are required to elucidate the precise mechanism preventing cyclin D1 nuclear accumulation in postmitotic neurons.
We show that expression of NLS-tagged cyclin D1 or coexpression of p21 with wild-type cyclin D1 induced apoptosis in differentiated cortical neurons, whereas the wild-type expression alone did less effectively. Owing to low infection efficiency after 4 days in culture, however, we were unable to examine the effect of wild-type cyclin D1 expression on fully differentiated neurons. Since cyclin D1 overexpression induces apoptosis in growing neuroblastoma cells (Kranenburg et al., 1996) , apoptotic cells produced by wild-type cyclin D1 are likely to be derived from a population of progenitor cells that are differentiating, but still retain the ability of cyclin D1 nuclear import at the time when infected (2 days). A role of cytoplasmic sequestration of cyclin D1 in neuronal survival is further supported by the fact that cyclin D1 redistributes from the cytoplasm to the nucleus under apoptotic conditions, which is consistent with previous observations (Padmanabhan et al., 1999; Timsit et al., 1999; Ino and Chiba, 2001) . Accumulating evidence has demonstrated that the neuronal cell death is a consequence of inappropriate activation of CDK activity. Specifically, the evidence that inhibition of CDK activity by expression of dominant-negative mutants of CDK4 and CDK6, but not that of CDK2, suppresses neuronal death (Park et al., 1997a) indicates that cyclin Ddependent kinase activity plays a critical role in this process. Thus, our results support the notion that nuclear translocation of cyclin D1 following neuronal insults may trigger cell death in postmitotic neurons via inappropriate activation of the Rb pathway.
Materials and methods
Preparation of cortical neurons and cell culture
Embryonic cortices were dissected from embryonic day 15.5 (E15.5) C57BL6 mice, then digested with 0.25% trypsin and 0.1% DNase I for 10 min at 371C. After trituration and filtration through a 40 mm membrane, cells were plated at a density of 1 Â 10 7 per 10 cm plate or 4 Â 10 5 per 24-well plate, both of which were precoated with 0.2% polyethylenimine (Sigma), and then incubated in Neurobasal medium (Gibco BRL) supplemented with 0.5 mm glutamine and 2% B27 (Gibco BRL).
Recombinant adenoviruses
Recombinant adenovirus encoding cyclin D1 (Ad-cyclin D1) (Albrecht and Hansen, 1999) and encoding dominant-negative GSK-3b (Ad-GSKdn) (Sears et al., 2000) were gifts from JH Albrecht and JR Nevins, respectively. Adx1w1 (Miyake et al., 1996) , Ad-D1NLS, Ad-CDK4 (Tamamori-Adachi et al., 2003) , and Ad-p21 (Tamamori et al., 1998) have been described. Viral stocks were prepared as described (Tamamori-Adachi et al., 2003) . Viral titers are defined as focusforming units (FFU) per milliliter. The MOI indicates the number of FFU per cell.
Western blotting
Cytoplasmic and nuclear extracts were prepared as described . Extracts prepared from equal numbers of cells were denatured and separated by 5-15% SDS-polyacrylamide gel electrophoresis and transferred onto PVDF membranes (Immobilon-P, Millipore). The blots were probed with primary antibodies overnight at 41C and bands were detected using secondary antibodies conjugated with horseradish peroxidase (Amersham Pharmacia Biotech) and a chemiluminescence detection system (Lumi-Lights Plus, Roche Diagnostics). We used the following antibodies: mouse monoclonal anti-cyclin D1 (Ab-3, Oncogene science), GSK3b (Transduction Laboratories), a-tubulin (TU-01, Zymed), Tau (Biosource), phospho-Tau (Thr181, Calbiochem), and cyclin D1 (72-13G) and p21 (F-5) antibodies (Santa Cruz Biotechnology), rabbit polyclonal anti-phospho-Rb Ser780 (New England Biolabs), cyclin D2 (M-20), cyclin D3 (C-16), CDK4 (C-22), CDK6 (C-21), Rb (M-153), p27 (C-19), E2F1 (C-20), and actin (H-196) antibodies (Santa Cruz Biotechnology). To determine nuclear and cytoplasmic ratios of cyclin D1 and CDK4, relative intensities of bands were scored by digital scanning and the ATTO densitograph program (Atto).
Immunofluorescent staining
Primary cortical neurons were fixed with methanol : acetone (1 : 1) for 10 min and for an additional 10 min with 4% paraformaldehyde at room temperature. Cells were stained with the rabbit polyclonal anti-cyclin D1 (H-295) or mouse monoclonal anti-cyclin D1 (72-13G) antibodies, followed by peroxidase-conjugated secondary antibodies (Histofine Simple Stain MAX PO, Nichirei). Immunostains were visualized using a fluorescent tyramide reagent according to the manufacturer's protocols (TSA-direct NEL-701, NEN), after which the cells were stained with the mouse monoclonal anti-MAP2 (HM-2, Sigma) or rabbit polyclonal neuron-specific type III b-tubulin isotype (a gift from Y Arimatsu) (Takiguchi-Hayashi et al., 1998) antibodies, followed by Alexa568-conjugated secondary antibodies (Molecular Probes). To double stain cells with cyclin D1 and nestin, the antinestin antibody (MAB353, Chemicon) was covalently labeled with Alexa 555 using the Zenon One Mouse IgG1 Labeling Kit (Molecular Probes). To detect apoptotic neurons, cells were assessed for TUNEL assay using an in situ Apoptosis Detection Kit (NeuroTACS, R&D Systems) according to the manufacturer's protocol, followed by staining with anticyclin D1 (72-13G) antibody and 1 mg/ml of DAPI. Images were acquired using a confocal microscope (LSM510, Carl Zeiss).
Cell cycle analysis
Cells seeded on coverslips were fixed in 70% ethanol at the indicated time, then incubated in propidium iodide (50 mg/ml) and RNase (100 mg/ml) for 30 min at 371C. Cell cycle profiles were analysed using a Laser Scanning Cytometer (LSC101, Olympus), as described (Tamamori-Adachi et al., 2003) .
Immunoprecipitation
Nuclear and cytoplasmic extracts prepared from equal numbers of cells were cleared with unconjugated magnetic beads (Dynabeads, Dynal) for 1 h at 41C, and immunoprecipitated with magnetic beads conjugated with polyclonal antibodies specific to Cdk4 (C-22) or p21 (C-19) for 2 h at 41C. The immunoprecipitates were washed twice with washing buffer A (20 mm Tris pH 8.0, 250 mm NaCl, 1 mm EDTA, 0.5% NP40) and twice with washing buffer B (20 mm Tris pH 8.0, 50 mm NaCl, 1 mm EDTA, 0.5% NP40), then Western blotted using anticyclin D1 (Ab-3), p21 (F-5), or p27 (F-8) antibodies.
